Publication: Effect of diabetes blood-stasis syndrome and Xuefu Zhuyu decoction on ERK1/2-VEGF signal pathway in rat retina Müller cells
Authors
Ye, Xiaofeng ; Ren, Hui ; Jiang, Tingting ; Zhang, Ting ; Li, Gang
item.page.secondaryauthor
item.page.director
Publisher
Universidad de Murcia, Departamento de Biologia Celular e Histiologia
publication.page.editor
publication.page.department
DOI
https://doi.org/10.14670/HH-18-427
item.page.type
info:eu-repo/semantics/article
Description
Abstract
Aims. This research was aimed to investigate
whether diabetic blood-stasis syndrome had a
relationship with ERK1/2-VEGF signaling pathway in
rat retina Müller cells and Traditional Chinese Drugs
designed for promoting blood circulation to remove
blood stasis had effectiveness for diabetic retinopathy
(DR) treatment.
Methods. Immunofluorescence was applied to
determine purity of Müller cells. Müller cells were
stimulated by blood serum obtained from rats with
blood-stasis syndrome and then treated by Xuefu Zhuyu
decoction. Western blot analysis, RT-PCR and ELISA
were used to measure the expression of VEGF. Western
blot analysis was used to determine the phosphorylation
of ERK1/2. The status of AP-1 DNA binding activity
was monitored by electrophoretic mobility shift assay
(EMSA).
Results. Stimulation of Müller cells by blood serum
of rat with diabetic blood stasis increased the secretion
of VEGF, activated ERK1/2 and AP-1 DNA-binding
activity. And treatment of Xuefu Zhuyu decoction could
weaken this phenomenon. What's more, ERK1/2
signaling pathway inhibitor U0126 also could inhibit the
expression of VEGF.
Conclusions. Diabetic blood-stasis syndrome in
theory of traditional Chinese Medicine has positive role
in regulating ERK1/2-VEGF signaling pathway.
Traditional Chinese drugs for promoting blood
circulation to remove blood stasis would be an effective
therapy to treat DR.
publication.page.subject
Citation
Histology and Histopathology Vol. 37, nº8 (2022)
item.page.embargo
Ir a Estadísticas
Este ítem está sujeto a una licencia Creative Commons. http://creativecommons.org/licenses/by-nc-nd/4.0/